Vince Martin

Vince Martin

Vince Martin has written investing advice for several years, covering stocks across a range of industries. A former registered representative, Martin saw the dot-com bubble inflate and burst in real time, creating a healthy respect for downside risk. He splits his time between Chicago and rural Wisconsin with his wife and three dogs.

Recent Articles

3 Big Stock Charts for Thursday: Akamai, Zynga, and U.S. Cellular

Thursday's big stock charts feature three names that rallied on Wednesday — because their sell-offs may have gone too far.

Why Exxon Mobil Stock Could Be Down for the Count

Some investors might view XOM as the victim of a panicked, short-term sell-off. But the long-term impacts are going to be severe.

How Microsoft Stock Highlights a Key Market Debate

Microsoft stock is down 29% from February highs, which seems like an obvious overreaction. But it's not if something else is at play.

Delta Air Lines Stock Isn’t a Buy — Yet

DAL stock has plunged over 40% in a matter of weeks, which might tempt bottom-timers. But there's no reason the declines can't or won't continue.

Where the FANG Stocks Sit in This Wild Market

The so-called 'FANG Stocks' led tech during its decade-long bull run. After a wild few weeks, here's how they're positioned going forward.

3 Big Stock Charts for Wednesday: ConEd, NovaGold, and Hain Celestial

Tuesday's rally bodes some promise, as investors returned to stock-picking. Wednesday's big stock charts highlight three of the winners.

At These Cheaper Prices, Ericsson Stock Is Even More Attractive

Ericsson stock already looked like the best play on 5G wireless growth. A market-driven sell-off leaves the stock cheap as well.

It’s Full Speed Ahead for Advanced Micro Devices Stock

AMD stock has pulled back amid the market rout. But Investor Day highlights the long-term opportunity now available at a cheaper price.

3 Big Stock Charts for Tuesday: Johnson & Johnson, J.M. Smucker, and Zscaler

Increasingly, it looks like this sell-off has causes well beyond the coronavirus. Tuesday's big stock charts might show why.

We’ve Seen the iBio Stock Story Before — And It Doesn’t End Well

IBIO stock has soared on hopes for a coronavirus vaccine. But similar theses in the past have led to huge losses.